ZYBT
Zhengye Biotechnology Holding Limited
1W: -9.5%
1M: -21.1%
3M: -60.3%
YTD: -37.2%
1Y: -84.9%
$0.71
-0.38 (-34.86%)
After Hours: $0.92 (+0.21, +28.87%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$33.6M
52W Range0.68-14.3
Volume127,400
Avg Volume21,837
Beta-4.21
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSonglin Song
Employees278
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2025-01-07
Websitejlzybio.com
No.1 Lianmeng Road
Jilin 132101
CN
Jilin 132101
CN
86 432 6304 7008
About Zhengye Biotechnology Holding Limited
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Latest News
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
Zhengye Biotechnology (NASDAQ:ZYBT) Shares Down 5.8% – What’s Next?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Liu Zhongyao | 0 | — | 2026-03-18 | |
| Sun Wenhua | 0 | — | 2026-03-18 | |
| Lian Wei | 0 | — | 2026-03-18 | |
| Han Aiden | 0 | — | 2026-03-18 |